Skip to main content
Walvax Biotechnology Co.,Ltd. logo

Walvax Biotechnology Co.,Ltd. — Investor Relations & Filings

Ticker · 300142 ISIN · CNE100000WN2 LEI · 300300H82R2DIQXA8N24 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,790 across all filing types
Latest filing 2025-04-11 Annual Report
Country CN China
Listing Shenzhen Stock Exchange 300142

About Walvax Biotechnology Co.,Ltd.

https://www.walvax.com

Walvax Biotechnology Co.,Ltd. is a biopharmaceutical enterprise specializing in the research, development, production, and distribution of vaccines and other biological products. The company focuses on modern biotechnology to address public health challenges through a diverse portfolio of preventive vaccines. Key products include the 13-valent pneumococcal polysaccharide conjugate vaccine (PCV13), the bivalent human papillomavirus (HPV) vaccine, and various combination vaccines for meningitis and Haemophilus influenzae type b (Hib). Walvax operates advanced R&D platforms and manufacturing facilities that comply with international quality standards. The company is actively involved in the development of next-generation vaccine technologies, including mRNA and recombinant protein platforms, aiming to provide affordable and high-quality immunization solutions for global markets.

Recent filings

Filing Released Lang Actions
2024年年度报告
Annual Report Classification · 100% confidence The document is titled '云南沃森生物技术股份有限公司2024 年年度报告全文' which translates to 'Yunnan Walvax Biotechnology Co., Ltd. 2024 Annual Report Full Text'. It contains detailed financial data for the year 2024, including net profit, revenue, quarterly financial indicators, management discussion and analysis, company governance, environmental and social responsibility, and other comprehensive sections typical of a full annual report. The document length is 15,000 characters, indicating a full report rather than a brief announcement. It includes signed financial statements and an audit report, confirming it is the full annual report. Therefore, the document fits the definition of an Annual Report (10-K). FY 2024
2025-04-11 Chinese
沃森生物：第五届董事会第二十五次会议决议公告
Board/Management Information Classification · 95% confidence The document is a detailed announcement of resolutions passed at a board meeting of Yunnan Watson Biotechnology Co., Ltd. It includes multiple governance-related decisions such as revisions to internal control systems, audit committee rules, ESG management, and the decision to dissolve a subsidiary. The document is titled as a board meeting resolution announcement and contains no financial statements or earnings data. It is not a full annual or interim report, nor an earnings release or audit report. The content focuses on board decisions and governance matters, including internal policies and committee rules. Therefore, the document fits best under the category of Board/Management Information (MANG). The document length is 4686 characters, which is consistent with a detailed board meeting resolution announcement rather than a full report.
2025-03-25 Chinese
董事会可持续发展委员会工作细则（2025年3月）
Governance Information Classification · 95% confidence The document is titled as the 'Board of Directors Sustainable Development Committee Working Rules' of Yunnan Watson Biotechnology Co., Ltd. It details the committee's composition, responsibilities, decision-making procedures, and meeting rules. The content focuses on governance related to sustainability and ESG (Environmental, Social, and Governance) matters, outlining internal rules and governance practices. There are no financial statements, audit opinions, earnings data, or announcements of voting results. The document is a governance framework document rather than a report or announcement. Therefore, it fits best under the category of Governance Information (CGR). The document length is 2773 characters, which is consistent with a detailed governance policy document rather than a brief announcement or a full report.
2025-03-25 Chinese
内幕信息知情人登记制度（2025年3月）
Governance Information Classification · 95% confidence The document is titled '内幕信息知情人登记制度' which translates to 'Insider Information Insider Registration System' and details the company's internal policies and procedures for managing insider information, including definitions, responsibilities, confidentiality, and record-keeping. It references relevant laws and regulations such as the Company Law, Securities Law, and Shenzhen Stock Exchange rules. The document includes attachments like insider information registration forms, major event progress memorandums, and confidentiality obligation letters. There are no financial statements, earnings data, or report summaries present. The content is focused on governance and compliance related to insider information management rather than financial results or corporate governance structure per se. It is a regulatory compliance document outlining internal rules and procedures for insider information management, which aligns best with Governance Information (CGR). The document length is sufficient and it is not a mere announcement or certification, so it is not RPA or RNS. Therefore, the classification is Governance Information (CGR).
2025-03-25 Chinese
董事会薪酬与考核委员会工作细则（2025年3月）
Governance Information Classification · 95% confidence The document is titled '云南沃森生物技术股份有限公司 董事会薪酬与考核委员会工作细则', which translates to 'Yunnan Watson Biotechnology Co., Ltd. Board of Directors Remuneration and Assessment Committee Working Rules'. The content details the structure, responsibilities, and procedures of the Board's Remuneration and Assessment Committee, including rules on remuneration, assessment, meeting procedures, and committee composition. There is no financial data, no report of financial results, no announcement of voting results, no legal proceedings, no capital changes, or other financial or regulatory filings. The document is a governance-related internal rules document about board committee operations and remuneration policies. This fits the definition of Governance Information (CGR), which covers reports detailing the company's internal rules, board structure, and governance practices. The document length is 2537 characters, which is sufficient for a detailed governance document and not a brief announcement. Therefore, the correct classification is CGR with high confidence.
2025-03-25 Chinese
内部审计工作制度（2025年3月）
Audit Report / Information Classification · 95% confidence The document is titled '内部审计工作制度' which translates to 'Internal Audit Work System' and details the internal audit policies, responsibilities, organizational structure, procedures, and legal responsibilities of the internal audit function within the company. It references relevant laws and regulations governing internal audit work and outlines the audit committee's role and audit staff duties. The document is a policy or procedural manual for internal audit rather than a standalone audit report, financial statement, or regulatory filing. It does not contain financial data, audit opinions on financial statements, or results of audit tests. It is not an announcement or a report publication notice but a governance or internal control related document. Given the content focuses on internal audit policies and procedures, it best fits under the category of Audit Report / Information (AR), which includes applied accounting principles and internal audit information, excluding full annual reports. The document length (5585 characters) supports it being a substantive policy document rather than a brief announcement.
2025-03-25 Chinese

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.